PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 158 filers reported holding PRECIGEN INC in Q1 2023. The put-call ratio across all filers is 1.69 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $66,740 | +23.5% | 47,000 | 0.0% | 0.01% | +50.0% |
| Q2 2023 | $54,050 | +8.5% | 47,000 | 0.0% | 0.00% | -20.0% |
| Q1 2023 | $49,820 | -30.3% | 47,000 | 0.0% | 0.01% | -28.6% |
| Q4 2022 | $71,440 | -28.6% | 47,000 | 0.0% | 0.01% | -30.0% |
| Q3 2022 | $100,000 | +58.7% | 47,000 | 0.0% | 0.01% | +66.7% |
| Q2 2022 | $63,000 | -36.4% | 47,000 | 0.0% | 0.01% | -33.3% |
| Q1 2022 | $99,000 | -34.0% | 47,000 | +16.3% | 0.01% | -30.8% |
| Q4 2021 | $150,000 | -25.7% | 40,420 | 0.0% | 0.01% | -31.6% |
| Q3 2021 | $202,000 | -23.5% | 40,420 | 0.0% | 0.02% | -24.0% |
| Q2 2021 | $264,000 | -5.0% | 40,420 | 0.0% | 0.02% | -10.7% |
| Q1 2021 | $278,000 | -32.5% | 40,420 | 0.0% | 0.03% | -41.7% |
| Q4 2020 | $412,000 | +192.2% | 40,420 | 0.0% | 0.05% | +152.6% |
| Q3 2020 | $141,000 | -30.2% | 40,420 | 0.0% | 0.02% | -32.1% |
| Q2 2020 | $202,000 | +47.4% | 40,420 | 0.0% | 0.03% | +21.7% |
| Q1 2020 | $137,000 | – | 40,420 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |